AXM Pharma, Inc. (OTCPK: AXMP)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
AXM Pharma, Inc. (OTCPK: AXMP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.41K.
trading between 0.00 and 0.00.
Tweenvest scores AXM Pharma, Inc. across four factors: quality 68/100, value 32/100. Its strongest factor is quality.
AXMP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.41K
- Revenue (TTM)
- $110.68M
- P/E
- 0.00
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- -87.60
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.41B
- Employees
- —
- Next earnings
- —
About AXM Pharma, Inc.
AXM Pharma, Inc. produces and distributes both over-the-counter and prescription medications for sale within the People's Republic of China. The firm operates from its headquarters in New York, New York.
- ISIN
- US0024571095
- Listed since
- Oct 15, 2018
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.